Access to anti-retroviral drugs, female in Australia
Australia: Access to anti-retroviral drugs, female was 87.0% in 2023. ▲ Rising
Access to anti-retroviral drugs, female in Australia, 2000–2023
Source: UNAIDS estimates. Measured in %.
Analysis
In 2023, access to anti-retroviral drugs, female in Australia stood at 87.0%. That is the highest value across all 24 years on record.
The figure is up 7.4% on the previous year and up 42.6% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Australia peaked at 87.0% in 2023 and was at its lowest, 49.0%, in 2003.
Australia ranks 45th of 141 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 24 years of available data.
Access to anti-retroviral drugs, female in Australia, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 53.0% | — |
| 2001 | 54.0% | +1.9% |
| 2002 | 50.0% | -7.4% |
| 2003 | 49.0% | -2.0% |
| 2004 | 49.0% | +0.0% |
| 2005 | 51.0% | +4.1% |
| 2006 | 53.0% | +3.9% |
| 2007 | 53.0% | +0.0% |
| 2008 | 52.0% | -1.9% |
| 2009 | 53.0% | +1.9% |
| 2010 | 58.0% | +9.4% |
| 2011 | 61.0% | +5.2% |
| 2012 | 63.0% | +3.3% |
| 2013 | 61.0% | -3.2% |
| 2014 | 63.0% | +3.3% |
| 2015 | 68.0% | +7.9% |
| 2016 | 69.0% | +1.5% |
| 2017 | 72.0% | +4.3% |
| 2018 | 73.0% | +1.4% |
| 2019 | 76.0% | +4.1% |
| 2020 | 79.0% | +3.9% |
| 2021 | 79.0% | +0.0% |
| 2022 | 81.0% | +2.5% |
| 2023 | 87.0% | +7.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 51.7% | 49.0% | 54.0% | 10 |
| 2010s | 66.4% | 58.0% | 76.0% | 10 |
| 2020s | 81.5% | 79.0% | 87.0% | 4 |
Countries ranked near Australia
More gender data for Australia
- Child population (UN estimates and projections) 4,759 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.0804 % change on previous year (2030)
- Population 23,430 (2030)
- Working-age population (UN estimates and projections) 23,430 (2030)
- Population (UN estimates and projections), annual growth rate 1.02 % change on previous year (2030)
- Age population, age 00, female, interpolated 149,630 (2025)
- Age population, age 00, male, interpolated 157,746 (2025)
- Age population, age 01, female, interpolated 150,777 (2025)
- Age population, age 01, male, interpolated 158,898 (2025)
- Age population, age 02, female, interpolated 151,066 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Australia?
- Access to anti-retroviral drugs, female in Australia was 87.0% in 2023, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Australia?
- The highest recorded value was 87.0% in 2023.
- What is the lowest access to anti-retroviral drugs, female recorded in Australia?
- The lowest recorded value was 49.0% in 2003.
- How does Australia rank for access to anti-retroviral drugs, female?
- Australia ranks 45th out of 141 countries with data for 2023.
- Is access to anti-retroviral drugs, female rising or falling in Australia?
- Over the last ten years it is up 42.6%. The long-run trend across the full record is rising.
- Where does this Australia data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.